Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Clinical Pharmacokinetic Study of Cardionat®, Capsules 250 mg (JSC Nizhpharm, Russia) Using in Health Athlete Volunteers

NCT02758912 is registered in ClinicalTrials.gov with Burnasyan Federal Medical Biophysical Center as lead sponsor.

NCT NCT02758912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02758912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Clinical Pharmacokinetic Study of Cardionat®, Capsules 250 mg (JSC Nizhpharm, Russia) Using in Health Athlete Volunteers
Lead sponsor
Burnasyan Federal Medical Biophysical Center
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2016
Completion date
October 25, 2019
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angina pectoris, stroke, not specified as hemorrhage or infarction